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Abstract 28 
 29 
Introduction 30 
The Metabolomics Society Data Quality Task Group (DQTG) developed a 31 
questionnaire regarding quality assurance (QA) and quality control (QC) to 32 
provide baseline information about current QA and QC practices applied in the 33 
international metabolomics community.  34 
 35 
Objectives 36 
The DQTG has a long-term goal of promoting robust QA and QC in the 37 
metabolomics community through increased awareness via communication, 38 
outreach and education, and through the promotion of best working practices. 39 
An assessment of current QA and QC practices will serve as a foundation for 40 
future activities and development of appropriate guidelines. 41 
 42 
Method 43 
QA was defined as the set of procedures that are performed in advance of 44 
analysis of samples and that are used to improve data quality. QC was defined as 45 
the set of activities that a laboratory does during or immediately after analysis 46 
that are applied to demonstrate the quality of project data. A questionnaire was 47 
developed that included 70 questions covering demographic information, QA 48 
approaches and QC approaches and allowed all respondents to answer a subset 49 
or all of the questions. 50 
 51 
Result 52 
The DQTG questionnaire received 97 individual responses from 84 institutions 53 
in all fields of metabolomics covering NMR, LC-MS, GC-MS, and other analytical 54 
technologies.  55 
 56 
Conclusion 57 
There was a vast range of responses concerning the use of QA and QC 58 
approaches that indicated the limited availability of suitable training, lack of 59 
Standard Operating Procedures (SOPs) to review and make decisions on quality, 60 
and limited use of standard reference materials (SRMs) as QC materials. The 61 
DQTG QA/QC questionnaire has for the first time demonstrated that QA and QC 62 
usage is not uniform across metabolomics laboratories. Here we present 63 
recommendations on how to address the issues concerning QA and QC 64 
measurements and reporting in metabolomics.  65 
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Introduction 67 
 68 
Metabolomics is a scientific approach applied to the systems analysis of 69 
metabolism [Dunn 2011] operating in microbes, plants and animals [Furusawa 70 
2013; Kusano 2015; Cheng 2015]. The discipline of metabolomics is less than 20 71 
years of age [Oliver 1998] although the roots are much older [Pauling 1971]. 72 
Metabolomics studies typically use a pipeline from experimental design through 73 
analytical measurements (sample preparation and data acquisition) to 74 
bioinformatics processing (data processing and statistical analysis) [Brown 75 
2005]. The validity of and confidence in the biological conclusions resulting from 76 
this pipeline are highly dependent on the quality of the procedures applied 77 
during the metabolomics study. The appropriate application of quality assurance 78 
(QA) and quality control (QC) processes are important but are often overlooked 79 
in metabolomics. In targeted metabolite studies, guidelines are available to guide 80 
the scientist in some aspects of the process including the most frequently applied 81 
Food and Drug Administration (FDA) guidelines for bioanalytical method 82 
validation [http://www.fda.gov/downloads/Drugs/Guidance/ucm070107.pdf.] 83 
as well as other materials [Garfield 2000; Hibbert 2007; Westgard 2008; Booth 84 
2015]. However, there are currently no clear guidelines for untargeted 85 
metabolomic studies. 86 
 87 
The Metabolomics Society’s mission includes ‘To promote the growth and 88 
development of the field of metabolomics internationally” [Metabolomics Society 89 
website]. To address this mission, several scientific task groups have been 90 
established to act for the community in areas requiring international community 91 
consensus. One of these is the Data Quality Task Group (DQTG) chaired by Drs. 92 
Daniel Bearden and Richard Beger. The DQTG promotes robust QA and QC in the 93 
metabolomics community through increased awareness via communication, 94 
outreach and education, and through the promotion of best working practices 95 
[Bearden 2014; Metabolomics Society task group website]. One objective of this 96 
task group is to define the current application levels of QA and QC processes in 97 
both targeted and untargeted studies across all applications in metabolomics. To 98 
complete this objective, the task group operated a questionnaire for 2 months 99 
(August – September 2015) via the SurveyMonkey website 100 
(https://www.surveymonkey.com), which was advertised via e-mail alerts, 101 
Metabolomics Society web pages, Twitter and MetaboNews newsletters. The 102 
questionnaire included 70 questions covering demographic information, QA 103 
approaches and QC approaches and allowed all respondents to answer a subset 104 
or all of the questions. All responses are available in the supplementary 105 
information and on the Metabolomics Society website [13]. Here we will 106 
summarize the most important information and facts derived from the 107 
questionnaire and a number of important recommendations. 108 
 109 
The respondents 110 
 97 respondents  111 
 36 % were principal investigators (PIs) or group leaders, 14 % were staff 112 
scientists, 20 % were post-doctoral researchers and 19 % were PhD 113 
students.  114 
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 11 % of respondents had less than 2 years of experience in metabolomics 115 
with 31 % having greater than 8 years experience.  116 
 The respondents applied metabolomics in a diversity of different 117 
applications and many respondents worked across multiple disciplines 118 
including clinical sciences (65 %), toxicology (35 %) and systems biology 119 
(45 %).  120 
 70 % responded as working in a combination of a biological/chemical 121 
laboratory and data processing/bioinformatics.  122 
 Greater than 70 % of respondents worked with cells, biofluids and tissues 123 
and investigated microbes (42 %), plant (34 %), mammals (62 %) and 124 
humans (76 %). 73 % and 88 % of respondents applied targeted and 125 
untargeted assays, respectively, with 34 % applying NMR spectroscopy in 126 
their studies, 83 % applying liquid chromatography-mass spectrometry 127 
and 50 % applying gas chromatography-mass spectrometry.  128 
 74 % of respondents investigated less than 200 samples in a typical 129 
biological study and 63 % studied less than 5000 total biological samples 130 
each year. 131 
 132 
Training 133 
Quality processes include training and competence assessment to ensure a 134 
minimum quality-level is associated with processes involving staff. 65 % of 94 135 
responses defined that they operate in an environment with no in-house training 136 
program and 74 % were not required to be involved in ongoing continuous 137 
professional education. In environments where training was conducted (33 138 
responses), professional staff (49 %) and post-doctoral/graduate staff (36 %) 139 
were the major providers of training. Where training is provided, only 21 % of 140 
instrument operators have to pass a certification test after training, with 57 % 141 
applying professional staff to perform the assessment. 79 % of 85 responses do 142 
not operate in an environment where there was a requirement to pass a 143 
certification test after training. 73 % of 33 responses applied periodic checks of 144 
professional practice with 58 % of checks performed by professional staff as 145 
indicated by 33 responses. 146 
 147 
Standard Operating Procedures 148 
The mistakes that can be introduced into metabolomics experiments through 149 
improper or inconsistent pre-analytical or analytical procedures may cause the 150 
data to be inaccurate or invalid, and this may lead to erroneous findings and 151 
conclusions. For examples see [Gika 2008; Bernini 2011; Kamlage 2014; Dunn 152 
2012]. Consistent procedures as simple as pipetting, balance usage, sample 153 
cross-contamination control, proper preparation of solvents and sample 154 
extraction techniques all contribute to the veracity of the analytical 155 
measurements and should be thoroughly documented in Standard Operating 156 
Procedures (SOPs) and enforced in training programs. For long-term studies or 157 
interlaboratory studies, SOPs are essential for communicating well and ensuring 158 
the consistency of the data. 159 
 160 
Eighty-seven respondents answered questions related to SOPs. SOPs were 161 
available in the laboratories of 76 % of respondents with 58 % developed in-162 
house and a further 37 % developed from in-house and published methods. 163 
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When investigated in more detail, 90 % of respondents had access to SOPs for 164 
sample extraction, 53 % for sample storage, 75 % for analytical instruments, 165 
52 % for assessment of data from QC samples and 33 % for deciding when QC 166 
data from instrumental analysis has failed and defining how to correct the 167 
instrumental data. As a matter of concern and shown for 84 responses was that 168 
70 % of respondents did not have access to a protocol for independent review of 169 
quality-related results (Figure 1A) and 80 % did not have access to a written 170 
protocol of QA review criteria (Figure 1B).  171 
 172 
Sample measurement validation 173 
The majority of respondents (82 responses) validate sample measurements with 174 
73 % using repeat sample extractions and analyses, 87 % performing repeated 175 
analysis of the same sample and 54 % analyzing a historical sample periodically 176 
(Figure 2). 88 % of 80 responses analyze a blank sample with extraction 177 
performed as for biological samples. Blank samples were analyzed either at the 178 
start and end of the analytical batch (28 %), at regular intervals (44 %) or 179 
randomly (21 %) as defined in 68 responses. 78 % of respondents operated a 180 
process to reduce carryover (80 responses) and 91 % randomize the order of 181 
sample analysis (80 responses). 94 % operated instrument condition checks and 182 
79 % of 80 responses did not apply standard reference materials (SRMs); when 183 
applicable, 47 % applied a SRM once or less than once a day and 16 % greater 184 
than once per day. Methods for reporting of QC data were variable in the 80 185 
responses collected; 34 % reported precision measurements for each metabolite, 186 
45 % report a single range of precisions for all metabolites, 24 % report QC data 187 
on a boxplot, 56 % visualize QC samples on a PCA scores plot and 56 % provide a 188 
descriptive statement of the QC results.  189 
 190 
QC samples 191 
Of 80 responses, 83 % of respondents applied pooled project materials and 48 % 192 
applied standard reference materials (SRMs) as QC materials. This contradicts 193 
the results for SRM use as defined above in the sample measurement validation 194 
section. Figure 3 illustrates how often QC samples were applied for different 195 
processes including the assessment of consistency in sample preparation (80 %) 196 
and chromatography column integrity (76 %). Importantly, 59 % of respondents 197 
applied replicate extractions and 69 % applied replicate analytical 198 
measurements with 85 % analyzing individual samples and 15 % analyzing a 199 
single pooled sample.  200 
 201 
Data storage 202 
Of 84 responses, 89 % store data in an archive, with 95 % of data storage being 203 
performed in an in-house archive. A lower percentage (73 %) archived QA/QC 204 
data. 205 
 206 
Inter-laboratory comparisons 207 
Of 82 responses, 33 % had participated in an inter-laboratory comparison study 208 
and 48 % were interested in participating in a future inter-laboratory 209 
comparison.  210 
 211 
Laboratory accreditation 212 
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Of 85 responses, 89 % were not required to meet laboratory accreditation and 213 
74 % were not voluntarily attempting to meet any accreditation.  214 
 215 
 216 
 217 
Biggest issues in QA and QC implementation and processes 218 
The most frequent comments related to the currently regarded biggest issues in 219 
QA and QC are detailed below: 220 
 Training including staff turnover and lack of training available outside the 221 
organization 222 
 SOP formalization, consistency and maintenance including reported 223 
changes to published methods (for example papers published in Nature 224 
Protocols) 225 
 Ensuring routine compliance to SOPs and QA processes 226 
 Insufficient control over sample collection and sampling consistency 227 
 Inadequate availability of reference standards, isotopically labeled 228 
compounds, QC samples and SRMs 229 
 Providing a balance between QA/QC and sample throughput 230 
 QC does not contribute to assessment of output by the wider community 231 
and there is a need for true standards across the community 232 
 A global strategy for QA/QC and its review is required 233 
 Establishment of QC acceptance criteria as currently there is a lack of 234 
reported QC results and acceptance criteria 235 
 Additional measures beyond pooled QC samples 236 
 237 
Key conclusions and recommendations 238 
1. The level of training, both in-house and external to the organization, is low; 239 
65 % of responses replied that they operate in an environment with no in-house 240 
training program. 74 % of responses were not required to be involved in ongoing 241 
continuous professional education. 242 
Recommendation: Enhance training focused on QA and QC available as online and 243 
face-to-face courses (for example, the Birmingham Metabolomics Training Centre 244 
operates a 2-day course focused on QA and QC processes). 245 
 246 
2. 76 % of respondents applied SOPs. However, 70 % of respondents did not 247 
have access to a protocol for review of quality and 80 % did not have access to 248 
protocols focused on a review of quality processes. 249 
Recommendation: Appropriate agencies and the Metabolomics Society should 250 
provide guidance on quality assurance processes and their review; develop 251 
consensus processes through specialist meetings and reports. 252 
 253 
3. The majority of respondents validate sample measurements, apply sample 254 
blanks, apply protocols to minimize sample carryover and randomize the 255 
analysis order of biological samples. 256 
Recommendation: To provide education to the metabolomics community, with an 257 
emphasis on early career scientists, on sample measurement validation, and to 258 
provide continuing education to ensure these good practices continue. 259 
 260 
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4. 83 % of respondents applied pooled project materials and 48 % applied 261 
standard reference materials (SRMs) as QC materials. 59 % of respondents 262 
applied replicate extractions and 69 % applied replicate analytical 263 
measurements. 264 
Recommendation: To provide education to the metabolomics community, with an 265 
emphasis on early career scientists, on usage of quality materials, and to provide 266 
continuing education to ensure these good practices continue. 267 
 268 
5. 79 % of respondents did not access SRM materials. 269 
Recommendation: To communicate with the metabolomics community to define 270 
the types and volumes of SRMs required. 271 
  272 
6. 33 % had participated in an inter-laboratory comparison study and 48% were 273 
interested in participating in a future inter-laboratory comparison. 274 
Recommendation: To communicate with the metabolomics community to define 275 
the types and frequency of inter-laboratory comparison exercises and encourage 276 
independent agencies to support inter-laboratory exercises. 277 
 278 
7. 89 % of respondents were not required to meet laboratory accreditation and 279 
74 % were not voluntarily attempting to meet any accreditation.  280 
Recommendation: To investigate the requirement for laboratory accreditation 281 
with the regulatory agencies, funding bodies, the Metabolomics Society and the 282 
metabolomics community. 283 
 284 
8. There is little incentive for laboratories to improve their QA/QC practices, 285 
especially given the non-trivial costs associated with a thorough QA/QC 286 
program.  287 
Recommendation: Recognizing the need to provide further incentive for 288 
laboratories to improve overall QA/QC practices, expert panels should be convened 289 
to develop workable, practical QA/QC recommendations and guidelines. One 290 
possible mechanism is a workshop currently being planned for later in 2017 that 291 
will define appropriate QA/QC frameworks that may be adopted widely in 292 
laboratories and, possibly, by funders, data repositories and scientific publishers. 293 
 294 
 295 
Disclaimer 296 
The opinions expressed in this publication do not necessarily represent those of 297 
the U.S. Food and Drug Administration or the National Institute of Standards and 298 
Technology. Certain commercial equipment, instruments, or materials are 299 
identified in this paper to specify adequately the experimental procedure. Such 300 
identification does not imply recommendation or endorsement by the National 301 
Institute of Standards and Technology, nor does it imply that the materials or 302 
equipment identified are necessarily the best available for the purpose. 303 
Reference to the content of this paper for commercial advertising purposes with 304 
regard to commercial equipment, instruments, or materials is prohibited (15 305 
CFR 200.113). 306 
 307 
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Figure Captions 401 
 402 
Figure 1. A) Responses to “Do you have a protocol for independent review of 403 
quality-related results?”; B) Responses to “Do you have a written protocol for QA 404 
review criteria?” 405 
 406 
Figure 2. Average response to “Do you validate your project sample 407 
measurements with: (Check all that apply)?”  408 
 409 
Figure 3. Average responses to “What types of QC materials do you routinely use 410 
in analytical measurements for metabolomics projects? (Check all that apply)? 411 
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